🇦🇺 Australia Country × Condition
lung cancer Clinical Trials in Australia
Active clinical trials for lung cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT06060613 Phase 1, Phase 2
Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Enrollment
208 pts
Country
🇦🇺 Australia
Obsidian Therapeutics, Inc.
View Trial → NCT06337084 Phase 1
Recruiting
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Country
🇦🇺 Australia
PMV Pharmaceuticals, Inc
View Trial → NCT06617169 Phase 1
Recruiting
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → NCT05030207
Recruiting
Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy
Enrollment
30 pts
Country
🇦🇺 Australia
University of Sydney
View Trial → Frequently Asked Questions
How many lung cancer clinical trials are active in Australia?
There are currently 5 active clinical trials for lung cancer with sites in Australia, of which 5 are actively recruiting patients.
How can I join a lung cancer clinical trial in Australia?
To join a lung cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lung cancer trials in Australia?
Active lung cancer trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology